Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · Real-Time Price · USD
5.76
-0.38 (-6.19%)
May 13, 2025, 4:00 PM - Market closed

Coya Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
35.5338.3432.635.934.348.72
Cash & Short-Term Investments
35.5338.3432.635.934.348.72
Cash Growth
-1.27%17.51%449.85%36.72%-50.23%-
Other Receivables
-0.737.5--0
Receivables
-0.737.5--0
Prepaid Expenses
2.845.241.071.250.240.03
Total Current Assets
38.3744.3141.27.184.588.75
Property, Plant & Equipment
0.030.040.070.090.12-
Long-Term Deferred Charges
---1.120.09-
Total Assets
38.444.3541.268.44.798.75
Accounts Payable
1.691.591.161.820.860.45
Accrued Expenses
1.811.392.252.010.29-
Current Income Taxes Payable
--0.72---
Current Unearned Revenue
0.840.850.92---
Total Current Liabilities
4.343.825.053.821.150.45
Long-Term Debt
---12.97--
Long-Term Unearned Revenue
0.690.950.57---
Total Liabilities
5.044.775.6316.791.150.45
Common Stock
000000
Additional Paid-In Capital
81.4180.3161.50.680.470.24
Retained Earnings
-48.04-40.74-25.86-17.87-5.62-0.73
Comprehensive Income & Other
---0.01---
Total Common Equity
33.3739.5835.64-17.19-5.15-0.49
Shareholders' Equity
33.3739.5835.64-8.393.648.3
Total Liabilities & Equity
38.444.3541.268.44.798.75
Total Debt
---12.97--
Net Cash (Debt)
35.5338.3432.63-7.034.348.72
Net Cash Growth
-1.27%17.51%---50.23%-
Net Cash Per Share
2.252.523.21-2.711.684.74
Filing Date Shares Outstanding
16.7216.7214.549.952.591.84
Total Common Shares Outstanding
16.7216.7114.412.592.591.84
Working Capital
34.0340.4836.143.363.448.3
Book Value Per Share
2.002.372.47-6.64-1.99-0.27
Tangible Book Value
33.3739.5835.64-17.19-5.15-0.49
Tangible Book Value Per Share
2.002.372.47-6.64-1.99-0.27
Machinery
-0.140.140.140.14-
Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q